Teva Earnings Miss by Record

The drugmaker’s bestseller was undercut by a rival

Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic medicines, fell short of analysts’ estimates as a key competitor began selling a cheaper version of its bestselling drug Copaxone in the U.S. The 4.88 percent miss is the widest margin on record. The shares, which had dropped 61 percent this year in the U.S. throught Wednesday, fell in New York and in Israel.

    Before it's here, it's on the Bloomberg Terminal.